Trexquant Investment LP Avrobio, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $16,172 - $50,649	-12,537 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $86,011 - $150,832	-24,931 Reduced 66.54%	12,537 $48,000
Q3 2021 Nov 12, 2021	BUY	$5.53 - $9.28 $207,198 - $347,703	37,468 New	37,468 $209,000
Q4 2020 Feb 11, 2021	SELL	$12.79 - $17.1 $387,780 - $518,454	-30,319 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$12.99 - $19.41 $127,250 - $190,140	-9,796 Reduced 24.42%	30,319 $395,000
Q2 2020 Aug 07, 2020	BUY	$12.19 - $22.96 $238,046 - $448,362	19,528 Added 94.86%	40,115 $700,000
Q1 2020 May 08, 2020	BUY	$10.08 - $27.21 $207,516 - $560,172	20,587 New	20,587 $320,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.